Jesús Martín

Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma

Bruno Paiva, Noemí Puig, María‐Teresa Cedena et al. · Journal of Clinical Oncology · 2019 · 261 citations · Full text

Sustained Remissions of High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome After Reduced-Intensity Conditioning Allogeneic Hematopoietic Transplantation: Chronic Graft-Versus-Host Disease Is the Strongest Factor Improving Survival

David Valcárcel, Rodrigo Martino, Dolores Caballero et al. · Journal of Clinical Oncology · 2007 · 231 citations

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 231 citations · Full text

Regenerative Medicine, Cell Therapy, Transplantation +7

Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma

Cristina Pérez, Cirino Botta, Aintzane Zabaleta et al. · Blood · 2020 · 151 citations · Full text

Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients

Bruno Paiva, María‐Teresa Cedena, Noemí Puig et al. · Blood · 2016 · 147 citations · Full text